Ad Scientiam supported by the PM’up program of the Ile-de-France Region

April 1st, 2021

Ad Scientiam was selected by the Ile-de-France Regional Council for the PM’up program.

Ad Scientiam's digital biomarker development project is fully aligned with the #Leader strategy developed by the Regional Council in favor of growth, employment and innovation in Ile-de-France


MSCopilot®: New clinical results confirm central role of digital biomarkers in the monitoring of patients with multiple sclerosis Our news